Lon S Schneider Selected Research

Apolipoprotein E4

9/2020	Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial.
1/2020	APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
3/2017	Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.
2/2017	Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.
1/2016	Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lon S Schneider Research Topics

Disease

107	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 01/2003
31	Dementia (Dementias) 01/2022 - 07/2003
27	Cognitive Dysfunction 08/2021 - 01/2004
12	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 01/2003
4	Schizophrenia (Dementia Praecox) 11/2011 - 02/2008
4	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 09/2007 - 04/2002
3	Disease Progression 01/2017 - 08/2011
3	Body Weight (Weight, Body) 02/2016 - 05/2009
3	Sleepiness 08/2011 - 03/2006
2	Atrophy 01/2022 - 10/2019
2	Amyloidosis 08/2021 - 01/2021
2	Hallucinations (Hallucination) 05/2016 - 01/2004
2	Major Depressive Disorder (Major Depressive Disorders) 06/2013 - 09/2003
2	Diarrhea 08/2011 - 04/2010
2	Dizziness (Lightheadedness) 04/2010 - 12/2009
1	Proteostasis Deficiencies 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2021
1	Memory Disorders (Memory Loss) 11/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Mental Disorders (Mental Disorder) 05/2016
1	Delirium 05/2015
1	Epistaxis (Nosebleed) 07/2014
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 07/2014

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2010
18	Antipsychotic Agents (Antipsychotics)IBA 01/2016 - 01/2003
15	Pharmaceutical PreparationsIBA 01/2022 - 02/2003
13	Citalopram FDA LinkGeneric 01/2017 - 01/2012
10	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2012 - 07/2003
9	Amyloid (Amyloid Fibrils)IBA 08/2021 - 01/2011
8	Memantine (Namenda)FDA Link 11/2019 - 01/2007
8	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2018 - 05/2003
8	Olanzapine (Zyprexa)FDA Link 01/2012 - 10/2005
7	Donepezil (Aricept)FDA LinkGeneric 11/2019 - 06/2004
7	Antidepressive Agents (Antidepressants)IBA 05/2015 - 11/2006
6	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2014
6	Sertraline (Zoloft)FDA LinkGeneric 01/2014 - 11/2006
5	Apolipoprotein E4IBA 09/2020 - 01/2016
5	Quetiapine Fumarate (Seroquel)FDA Link 01/2012 - 10/2005
4	ApolipoproteinsIBA 01/2022 - 05/2014
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2011
3	Biological ProductsIBA 01/2021 - 03/2015
3	Amyloid beta-PeptidesIBA 01/2021 - 12/2009
3	Valproic Acid (Depakote)FDA LinkGeneric 05/2015 - 08/2011
2	LipidsIBA 04/2022 - 05/2009
2	Pregnanolone (Allopregnanolone)IBA 01/2022 - 01/2020
2	NeurosteroidsIBA 01/2022 - 01/2020
2	Peptides (Polypeptides)IBA 08/2021 - 01/2011
2	Investigational DrugsIBA 01/2021 - 01/2016
2	Docosahexaenoic AcidsIBA 09/2020 - 03/2017
2	Therapeutic UsesIBA 01/2020 - 05/2016
2	Rivastigmine (Exelon)FDA LinkGeneric 11/2019 - 09/2007
2	ziprasidone (Geodon)FDA Link 11/2011 - 10/2005
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 04/2010 - 11/2006
2	Ginkgo biloba extract (Rokan)IBA 11/2008 - 12/2005
1	HDL LipoproteinsIBA 04/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	aducanumabIBA 11/2021
1	AcidsIBA 08/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 08/2021
1	florbetapirIBA 08/2021
1	EnzymesIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	Eicosapentaenoic AcidIBA 09/2020
1	Hormones (Hormone)IBA 01/2020
1	Cyclophilin AIBA 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2020
1	Sigma-1 ReceptorIBA 11/2019
1	maleic acid (maleate)IBA 11/2019
1	AMPA Receptors (AMPA Receptor)IBA 11/2019
1	Escitalopram FDA Link 11/2019
1	(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamateIBA 10/2019
1	sigma-2 receptorIBA 01/2019
1	pimavanserinIBA 01/2018
1	phenserineIBA 01/2018
1	crenezumabIBA 01/2018
1	Phospholipases (Phospholipase)IBA 03/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2017
1	Simvastatin (Zocor)FDA LinkGeneric 02/2017
1	CholesterolIBA 02/2017
1	Methylene Blue (Methylthioninium Chloride)FDA Link 12/2016
1	Lorazepam (Ativan)FDA LinkGeneric 05/2016
1	Hypnotics and Sedatives (Sedatives)IBA 03/2016
1	desmethylcitalopramIBA 02/2016
1	Threonine (L-Threonine)FDA Link 02/2015
1	Alanine (L-Alanine)FDA Link 02/2015
1	(2- (6- fluoro- 1H- indol- 3- yl)- ethyl)- (3- (2,2,3,3- tetrafluoropropoxy)benzyl)amineIBA 11/2014
1	davunetideIBA 07/2014
1	Indicators and Reagents (Reagents)IBA 07/2013

Therapy/Procedure

11	Therapeutics 01/2022 - 11/2006
4	Activities of Daily Living (ADL) 12/2016 - 07/2009
4	Home Nursing (Nursing, Home) 04/2012 - 01/2004
3	Precision Medicine 01/2021 - 01/2018
2	Secondary Prevention 01/2021 - 07/2013
1	Tertiary Prevention 01/2022
1	Long-Term Care 05/2016
1	Duration of Therapy 04/2013